The International Trade Commission has recently announced the following actions in intellectual property rights infringement investigations. For more information on pursuing or mitigating IPR-related import restrictions, please contact attorney Lee Sandler via email or at (305) 894-1000.
Adalimumab – institution of IPR infringement investigation 337-TA-1296 of adalimumab, processes for manufacturing or relating to same, and products containing same (complainants AbbVie Inc., AbbVie Biotechnology Ltd., and AbbVie Operations Singapore Pte. Ltd.; respondents located in Iceland, Germany, Switzerland, Israel, and the U.S.)
Integrated circuits – new patent infringement investigation 337-TA-1295 of integrated circuit products and devices containing same (complainant Future Link Systems LLC; respondents located in Cayman Islands, Taiwan, Hong Kong, and the U.S.)
Video processors – institution of patent infringement investigation 337-TA-1297 of video processing devices, components thereof, and digital smart televisions containing the same
Water filters – new patent infringement investigation 337-TA-1294 of high-performance gravity-fed water filters and products containing the same (complainant Brita LP; respondents located in China, Germany, and the U.S.)
Copyright © 2022 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.